Loading chart…
PRE-MARKET
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals, medicinal chemicals, and active pharmaceutical ingredients in India and internationally. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O, an antibiotic for the treatment of traveller's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin.
Gujarat Themis Biosyn Limited (GUJTHEM) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The GUJTHEM share price is ₹383.95 (-1.07% today), with a market capitalisation of ₹50B and a price-to-earnings (P/E) ratio of 85.9. MarketRipple tracks the GUJTHEM investment thesis, the ripple-chain impact of market events on Gujarat Themis Biosyn Limited, and the Healthcare sector outlook.
Open
₹385.35
High
₹389.75
Low
₹380.00
Prev. Close
₹388.10
52W High
₹470.05
52W Low
₹225.05
Day range
₹380.00–₹389.75
52-week range
₹225.05–₹470.05
Volume
19K
P/E
85.9
ROE
16.2%
D/E
0.56
Margin
28.0%
Gujarat Themis Biosyn Limited (NSE: GUJTHEM) is currently trading at ₹383.95 (-1.07%).
Gujarat Themis Biosyn Limited's market capitalization is ₹50B.
Gujarat Themis Biosyn Limited's price-to-earnings (P/E) ratio is 85.9.
Gujarat Themis Biosyn Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).